Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Ordination PD Dr. M. Hubalek

Schwaz, 6130, AustriaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Metastatic breast cancer

Running trials

Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
NCT05132582· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026

Report an error

Under construction, not live – Ordination PD Dr. M. Hubalek: trial site – Frontlight Research